Nov 4, 2015 6:30 am EST VolitionRx Announces Third Quarter 2015 Financial Results and Business Update
Oct 30, 2015 7:00 am EDT VolitionRx Schedules Third Quarter 2015 Earnings Conference Call and Business Update for Wednesday, November 4, 2015 at 8:30am ET
Oct 22, 2015 7:00 am EDT VolitionRx Demonstrates NuQ® Blood Test Detects 95% of Pancreatic Cancers in Second Preliminary Study
Oct 12, 2015 7:00 am EDT VolitionRx Announces Publication of Results from Pancreatic Cancer Study with Lund University in Clinical Epigenetics
Sep 22, 2015 7:00 am EDT VolitionRx Announces First CE Mark for NuQ(R) Blood Assay for Detection of Colorectal Cancer
Sep 9, 2015 8:00 am EDT VolitionRx Demonstrates NuQ(R) Blood Test Detects 81% of Colorectal Cancers and 67% of High Risk Adenomas in Large Double Blinded Clinical Trial
Sep 2, 2015 8:00 am EDT VolitionRx to Present at Rodman & Renshaw 17th Annual Global Investment Conference in New York and CNAPS IX Conference in Berlin on September 9 and 11, 2015
Sep 1, 2015 8:00 am EDT VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015
Aug 17, 2015 8:00 am EDT VolitionRx Announces Appointment of David Kratochvil as Chief Financial Officer
